| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.14▲ | 1.14▲ | 1.14▲ | 1.14▲ | 1.10▲ |
| MA10 | 1.14▲ | 1.15▼ | 1.14▲ | 1.14▲ | 1.22▼ |
| MA20 | 1.15▼ | 1.14▲ | 1.13▲ | 1.12▲ | 1.41▼ |
| MA50 | 1.13▲ | 1.14▲ | 1.14▲ | 1.26▼ | 3.24▼ |
| MA100 | 1.14▲ | 1.16▼ | 1.13▲ | 1.46▼ | N/A |
| MA200 | 1.18▼ | 1.13▲ | 1.18▼ | 2.09▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.001▲ | 0.003▲ | 0.010▲ | 0.334▲ |
| RSI | 56.750▲ | 56.295▲ | 55.377▲ | 48.051▼ | 32.088▼ |
| STOCH | 66.667 | 45.701 | 64.815 | 35.242 | 7.433▼ |
| WILL %R | -50.000 | -33.333 | -33.333 | -75.641▼ | -89.041▼ |
| CCI | -17.949 | 25.198 | 52.582 | 4.318 | -65.474 |
|
Tuesday, September 09, 2025 06:13 AM
Presentation to highlight findings from the first phase of the Company’s ongoing first-in-human proof-of-concept (PoC) clinical trial THE WOODLANDS, TX, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Autonomix ...
|
|
Thursday, September 04, 2025 06:31 AM
Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses the Company’s recently announced results from the post hoc analysis of its ...
|
|
Thursday, September 04, 2025 06:11 AM
Investorideas.com (Newswire), a go-to investing platform covering biotech and medtech stocks releases an industry snapshot looking at innovation and the importance of IP in medtech, featuring ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/09/25 | 1.15 | 1.16 | 1.14 | 1.145 | 63,884 |
| 16/09/25 | 1.11 | 1.145 | 1.10 | 1.14 | 190,606 |
| 15/09/25 | 1.12 | 1.16 | 1.11 | 1.12 | 91,547 |
| 12/09/25 | 1.15 | 1.18 | 1.09 | 1.11 | 139,900 |
| 11/09/25 | 1.15 | 1.18 | 1.14 | 1.16 | 136,900 |
| 10/09/25 | 1.19 | 1.202 | 1.14 | 1.16 | 155,600 |
| 09/09/25 | 1.15 | 1.19 | 1.13 | 1.19 | 141,237 |
| 08/09/25 | 1.12 | 1.17 | 1.09 | 1.17 | 200,398 |
| 05/09/25 | 1.05 | 1.138 | 1.05 | 1.115 | 148,500 |
| 04/09/25 | 1.15 | 1.165 | 1.06 | 1.075 | 477,400 |
|
|
||||
|
|
||||
|
|